ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,874.00
      -2.33%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      70.895
      -1.82%
      Bitcoin
      91,337.85
      4.57%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Citius Pharmaceuticals Inc (CTXR)

      7. Citius Pharmaceuticals Inc (CTXR) Financials

      Citius Pharmaceuticals Inc

      Citius Pharmaceuticals Inc (CTXR)

      NASDAQ
      0.20
      -0.1284
      (-39.10%)
      At close: November 15 4:00PM
      Delayed by 15 minutes
      0.1899
      -0.0101
      ( -5.05% )
      After Hours: 6:09PM
      Delayed by 15 minutes

      Citius Pharmaceuticals Inc Financial Summary

      The current CTXR market cap is 34.32M. The company's latest EPS is USD -0.1864 and P/E is -1.07.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 3.59M0000
      Operating Income -5.09M-10.13M-9.34M-10.97M-10.63M
      Net Income -8.77M-11.1M-9.23M-8.54M-10.9M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -15.6M-17.71M-23.53M-39.22M-36.73M
      Net Income -15.56M-17.55M-23.05M-39.54M-33.69M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 110.41M103.61M97.4M90.71M97.09M
      Total Liabilities 12.11M12.18M12.07M10.74M10.81M
      Total Equity 98.3M91.43M85.34M79.97M86.28M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 28.99M43.77M142.43M114M103.61M
      Total Liabilities 4.61M10.1M9.65M10.57M12.18M
      Total Equity 24.38M33.67M132.78M103.43M91.43M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -22.26M-29.06M-6.14M-13.92M-22.29M
      Investing N/A N/A N/A N/A N/A
      Financing 13.83M13.83M N/A N/A 13.72M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -12.44M-16.93M-24.25M-28.36M-29.06M
      Investing N/A -2k-40.01M N/A N/A
      Financing 11.15M22.9M120.47M N/A 13.83M

      Stats and Ratios

      Market Cap 34.32M
      Price to Earnings Ratio -1.07
      Price to Sales Ratio 0
      Price to Cash Ratio 1.37
      Price to Book Ratio 0.4
      Dividend Yield -

      Share Statistics

      Shares Outstanding 180.73M
      Average Volume (1 week) 3.5M
      Average Volume (1 Month) 1.46M
      52 Week Change -75.31%
      52 Week High 1.07
      52 Week Low 0.185
      Spread (Intraday) 0.01 (2.59%)

      Company Info

      Company Name Citius Pharmaceuticals Inc
      Address 112 north curry street
      carson city, nevada 89703
      Website https://www.citiuspharma.com
      Industry pharmaceutical preparations (2834)